Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK‐906), a dopamine D<sub>2</sub>/D<sub>3</sub> receptor antagonist, in patients with gastroparesis - Concepedia

Concepedia

Publication | Open Access

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK‐906), a dopamine D<sub>2</sub>/D<sub>3</sub> receptor antagonist, in patients with gastroparesis

DOI Full Paper Access

24

Citations

47

References

2021

Year

Braden Kuo, Cecilia Scimia, George E. Dukes, Wenwen Zhang, Saurabh Gupta, Chunlin Chen, Emil Chuang, Michael Camilleri

Alimentary Pharmacology & Therapeutics

Abstract

Trazpiroben was well tolerated with a favourable safety profile, supporting its further development for the treatment of gastroparesis. ClinicalTrials.gov identifier: NCT03268941.

References

	Year	Citations

Page 1